FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283078204> ?p ?o ?g. }

• W4283078204 endingPage "102974" @default.
• W4283078204 startingPage "102974" @default.
• W4283078204 abstract "E6 and E7 high-risk human papillomavirus (HR-HPV) oncoproteins are closely associated with the initiation and progression of cervical cancer (CC) and pre-cancerous lesions. Cervical high-grade squamous intraepithelial lesions (HSIL), as pre-cancerous lesions, have a 5% chance of progressing to invasive cancer. Topical 5-aminolevulinic acid photodynamic therapy (ALA-PDT) is a novel non-invasive targeted therapy for intraepithelial lesions. Herein, we analyzed the effect of HR-HPV E6/E7 mRNA on ALA-PDT for cervical HSIL. A retrospective analysis of 148 HR-HPV-positive patients diagnosed with cervical HSIL and receiving ALA-PDT was carried out. ALA-PDT was performed with 20% ALA thermosensitive gel, and irradiation at wavelength of 635 nm and density of 80–100 J/cm2 for 20–30 min. The therapeutic instruments of LED and semiconductor laser were applied for cervical lesions and lesions in endocervical canal, respectively. All patients were tested for HPV E6/E7 mRNA before and after PDT, and then followed up at 3, 6, and 12 months after treatment, and every six months thereafter. At the 6-month follow up, the complete remission (CR) rate of patients’ lesions was 86.5% (128/148), whereas the total HPV clearance rate was 72.3% (107/148). It was evident that positive E6/E7 mRNA before treatment had a significant effect on HPV clearance rate (66.3% VS 81.4%, P = 0.045) and CR rate (80.9% VS 94.9%, P = 0.015). The E6/E7 mRNA associated with HPV16/18 and HPV16/18 combined with other HR-HPV (HPV16/18 and other HR-HPV) affected HPV clearance (P = 0.035) and lesions CR (P = 0.039), respectively. Moreover, persistently positive E6/E7 mRNA after treatment was closely associated with poor efficacy (HPV clearance rate: P = 0.000, CR rate: P = 0.000). Throughout the follow up period, two cases recurred but none of the patients progressed. This study has shown that ALA-PDT is an effective, safe, and alternative treatment for cervical HSIL, especially for the patients of childbearing age. However, its efficacy is relatively poor in patients with persistently positive E6/E7 mRNA before and after treatment, who are relatively insensitive to ALA-PDT." @default.
• W4283078204 created "2022-06-19" @default.
• W4283078204 creator A5014863372 @default.
• W4283078204 creator A5021219336 @default.
• W4283078204 creator A5021678671 @default.
• W4283078204 creator A5029570990 @default.
• W4283078204 creator A5039978170 @default.
• W4283078204 creator A5052787170 @default.
• W4283078204 creator A5068041333 @default.
• W4283078204 creator A5068200433 @default.
• W4283078204 creator A5073921239 @default.
• W4283078204 creator A5077372450 @default.
• W4283078204 creator A5085446360 @default.
• W4283078204 creator A5088174174 @default.
• W4283078204 date "2022-09-01" @default.
• W4283078204 modified "2023-09-26" @default.
• W4283078204 title "The effect of high-risk HPV E6/E7 mRNA on the efficacy of topical photodynamic therapy with 5-aminolevulinic acid for cervical high-grade squamous intraepithelial lesions" @default.
• W4283078204 cites W1665287743 @default.
• W4283078204 cites W1990324858 @default.
• W4283078204 cites W1995560321 @default.
• W4283078204 cites W2000351935 @default.
• W4283078204 cites W2017517248 @default.
• W4283078204 cites W2023210068 @default.
• W4283078204 cites W2028955232 @default.
• W4283078204 cites W2036087634 @default.
• W4283078204 cites W2036464528 @default.
• W4283078204 cites W2039382131 @default.
• W4283078204 cites W2040404177 @default.
• W4283078204 cites W2046591921 @default.
• W4283078204 cites W2082651961 @default.
• W4283078204 cites W2086993352 @default.
• W4283078204 cites W2098765233 @default.
• W4283078204 cites W2159416556 @default.
• W4283078204 cites W2163830942 @default.
• W4283078204 cites W22520275 @default.
• W4283078204 cites W2531643489 @default.
• W4283078204 cites W2605365014 @default.
• W4283078204 cites W2610813136 @default.
• W4283078204 cites W2664931613 @default.
• W4283078204 cites W2750092411 @default.
• W4283078204 cites W2765445603 @default.
• W4283078204 cites W2806741594 @default.
• W4283078204 cites W2884145325 @default.
• W4283078204 cites W2884751203 @default.
• W4283078204 cites W2917837889 @default.
• W4283078204 cites W2999125356 @default.
• W4283078204 cites W3001262658 @default.
• W4283078204 cites W3015112546 @default.
• W4283078204 cites W3029672148 @default.
• W4283078204 cites W3080786716 @default.
• W4283078204 cites W3090877164 @default.
• W4283078204 cites W3090960200 @default.
• W4283078204 cites W3097918264 @default.
• W4283078204 cites W3118909934 @default.
• W4283078204 cites W3154718361 @default.
• W4283078204 cites W3196524527 @default.
• W4283078204 cites W4206986610 @default.
• W4283078204 cites W4376522311 @default.
• W4283078204 cites W3189296973 @default.
• W4283078204 doi "https://doi.org/10.1016/j.pdpdt.2022.102974" @default.
• W4283078204 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35724936" @default.
• W4283078204 hasPublicationYear "2022" @default.
• W4283078204 type Work @default.
• W4283078204 citedByCount "1" @default.
• W4283078204 countsByYear W42830782042023 @default.
• W4283078204 crossrefType "journal-article" @default.
• W4283078204 hasAuthorship W4283078204A5014863372 @default.
• W4283078204 hasAuthorship W4283078204A5021219336 @default.
• W4283078204 hasAuthorship W4283078204A5021678671 @default.
• W4283078204 hasAuthorship W4283078204A5029570990 @default.
• W4283078204 hasAuthorship W4283078204A5039978170 @default.
• W4283078204 hasAuthorship W4283078204A5052787170 @default.
• W4283078204 hasAuthorship W4283078204A5068041333 @default.
• W4283078204 hasAuthorship W4283078204A5068200433 @default.
• W4283078204 hasAuthorship W4283078204A5073921239 @default.
• W4283078204 hasAuthorship W4283078204A5077372450 @default.
• W4283078204 hasAuthorship W4283078204A5085446360 @default.
• W4283078204 hasAuthorship W4283078204A5088174174 @default.
• W4283078204 hasConcept C102652120 @default.
• W4283078204 hasConcept C121608353 @default.
• W4283078204 hasConcept C126322002 @default.
• W4283078204 hasConcept C142724271 @default.
• W4283078204 hasConcept C178790620 @default.
• W4283078204 hasConcept C185592680 @default.
• W4283078204 hasConcept C2777343196 @default.
• W4283078204 hasConcept C2778220009 @default.
• W4283078204 hasConcept C2778580637 @default.
• W4283078204 hasConcept C2781323092 @default.
• W4283078204 hasConcept C71924100 @default.
• W4283078204 hasConcept C90924648 @default.
• W4283078204 hasConceptScore W4283078204C102652120 @default.
• W4283078204 hasConceptScore W4283078204C121608353 @default.
• W4283078204 hasConceptScore W4283078204C126322002 @default.
• W4283078204 hasConceptScore W4283078204C142724271 @default.
• W4283078204 hasConceptScore W4283078204C178790620 @default.
• W4283078204 hasConceptScore W4283078204C185592680 @default.
• W4283078204 hasConceptScore W4283078204C2777343196 @default.
• W4283078204 hasConceptScore W4283078204C2778220009 @default.

• next